Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a disastrous condition, which can be caused by a wide range of diseases, such as pneumonia, sepsis, traumas, and the most recent, COVID-19. Even though we have gained an improved understanding of acute lung injury/acute respiratory...
Main Authors: | Wenfang Zhu, Yiwen Zhang, Yinghong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1103309/full |
Similar Items
-
Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
by: Alessio Filippo Peritore, et al.
Published: (2021-05-01) -
Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
by: Ni Zhao, et al.
Published: (2022-08-01) -
Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
by: Ni Zhao, et al.
Published: (2022-12-01) -
Punicalin attenuates LPS-induced acute lung injury by inhibiting inflammatory cytokine production and MAPK/NF-κB signaling in mice
by: Wentao Ji, et al.
Published: (2023-04-01) -
Acute kidney injury due to cytokine storm in patients with COVID-19 infection
by: Sepehr Ebrahimi-Dehkordi, et al.
Published: (2021-10-01)